Navigational problems and an increased risk of developing prosopagnosia, or face blindness, have been associated with COVID-19 infection.
Long COVID is linked to reduced oxygen uptake in the brain, a new study reports. Researchers say the finding is significant as a lack of sufficient oxygen supply may be one of the mechanisms that cause brain fog, cognitive problems, and an increased risk of depression and anxiety in long COVID patients.
Extracts from two common wildflowers, tall goldenrod and eagle fern blocked SARS_CoV_2, the virus responsible for COVID-19, from entering human cells. Researchers warn the public they should not consume the plants as a means of self-treatment against coronavirus as they can be toxic. However, the findings could provide a new avenue to develop pharmaceutical treatments for COVID-19.
Regular exercise, good quality sleep, and maintaining a healthy diet may be key to preventing long-term complications following COVID-19 infection. Researchers found women who followed a healthy lifestyle had half of the risk of developing long-COVID compared to those with unhealthy lifestyles.
Nasal injections comprising platelet-rich plasma derived from a patient's blood improve symptoms of smell loss associated with COVID-19 infection.
Persistent symptoms associated with long-COVID including smell loss, brain fog, and respiratory issues, tend to resolve themselves within a year for patients who suffered mild COVID-19 infection.
A new COVID-19 vaccine developed by researchers at the CNB-CSIC appears to protect against infection of the brain and neurological symptoms associated with coronavirus.
More severe COVID-19 outcomes associated with age-related macular degeneration likely arise from a genetic predisposition in addition to higher levels of Pdgf in blood serum.
Autopsy tissue samples of 44 people who died of COVID-19 showed SAR-CoV-2, the virus responsible for coronavirus, spread throughout the body and to the brain, with traces of the virus lingering for 8 months.
Researchers identified two FDA-approved drugs that can mitigate or even eliminate the brain fog associated with COVID-19 infection.
Alzheimer's disease onset may be accelerated by viruses that inflame and disrupt signals from the olfactory system to the hippocampus, a new study reports.
Gene usage in the brains of those who suffered severe COVID-19 infections was similar to that observed in the aging brain. Researchers say COVID-19 is associated with molecular signatures of brain aging.
